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Background: Smoking has recently been established as a risk factor for rectal cancer. We examined whether the
smoking-related increase in rectal cancer differed by gender.
Methods: We followed 602,242 participants (49% men), aged 19 to 67 years at enrollment from four Norwegian
health surveys carried out between 1972 and 2003, by linkage to Norwegian national registries through December
2007. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated by fitting Cox proportional hazard
models and adjusting for relevant confounders. Heterogeneity by gender in the effect of smoking and risk of rectal
cancer was tested with Wald χ2.
Results: During a mean follow-up of 14 years, 1,336 men and 840 women developed invasive rectal cancer. Ever
smokers had a significantly increased risk of rectal cancer of more than 25% for both men (HR = 1.27, 95% CI = 1.11-1.45)
and women (HR = 1.28, 95% CI = 1.11-1.48) compared with gender-specific never smokers. Men smoking ≥20 pack-years
had a significantly increased risk of rectal cancer of 35% (HR = 1.35, 95% CI = 1.14-1.58), whereas for women, it
was 47% (HR = 1.47, 95% CI = 1.13-1.91) compared with gender-specific never smokers. For both men and women,
we observed significant dose–response associations between the risk of rectal cancer for four variables [Age at
smoking initiation in years (both ptrend <0.05), number of cigarettes smoked per day (both ptrend <0.0001), smoking
duration in years (ptrend <0.05, <0.0001) and number of pack-years smoked (both ptrend <0.0001)]. The test for
heterogeneity by gender was not significant between smoking status and the risk of rectal cancer (Wald χ2,
p -value; current smokers = 0.85; former smokers = 0.87; ever smokers = 1.00).
Conclusions: Smoking increases the risk of rectal cancer to the same extent in women as in men.
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An expert group at the International Agency for Research
on Cancer (IARC) recently re-evaluated the carcinoge-
netic effects of smoking in humans, and concluded that
smoking is a risk factor for both colon and rectal cancer
[1]. In a recently published study based on present cohort,* Correspondence: inger.gram@uit.no
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unless otherwise stated.we found that the increased risk of colon cancer due to
cigarette smoking may be greater in women than men [2].
The variation in the smoking epidemic by country and
gender was first described in a model focusing on the
four stages of the tobacco epidemic in Western coun-
tries [3] and later in a more gender-specific model [4].
In Norway, the prevalence of daily smoking was around
25% for women and 65% for men in the 1950s. During
the early 1970s, it increased to 32% for women and de-
creased to 52% for men. Since then, the prevalence of
daily smoking has decreased steadily among men, while
a decrease among women started only at the turn of theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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women, aged 16 to 74 years were daily smokers [5,6].
During the last 50 years, the incidence rate of rectal
cancer has increased dramatically in Norway. It was
about 5 per 100,000 for women and 6 per 100,000 for
men in the late 1950s. In 2007, which was the end of the
follow-up period in our study, the risk had more than
doubled to 12 per 100,000 for women and 17 per
100,000 for men [7].
The main purpose of our study was to examine if the
smoking-related increase in rectal cancer differed by
gender in a large Norwegian cohort.
Methods
Study population
The cohort included 652,792 Norwegians (49% men),
most of whom were aged 19 to 67 years at enrollment,
who participated in four different Norwegian health sur-
veys initiated by the National Health Screening Service
(now included in the Norwegian Institute of Public
Health). These surveys were conducted between 1972
and 2003: the Oslo study I (1972–1973), the Norwegian
counties study (1974–1988), the 40 years cohort (1985–
1999) and the Cohort of Norway (CONOR, 1994–2003).
The design and protocol of these surveys were very simi-
lar, but there were some modifications made during differ-
ent time periods, mainly to the questionnaires, regarding
smoking, alcohol consumption, physical activity and other
lifestyle factors [8-13].
Information was gathered through a baseline question-
naire and a short health examination. In most surveys,
the participants were given a supplementary question-
naire, which they completed at home and mailed back in
a pre-stamped envelope. The participation rates for the
different surveys varied from 56% to 88% [13]. The
present study was approved by the Regional Committee
for Medical Research Ethics South-East, Norway. More
details about the study population are described else-
where [2,14].
Exposure information
The smoking questions across the four health surveys
were similar, but not identical. All surveys had a baseline
questionnaire, which included a detailed assessment of
smoking habits, physical activity, and other lifestyle fac-
tors. The questionnaires included questions on current
and former smoking habits, smoking duration, and aver-
age number of cigarettes smoked per day; some, such as
the CONOR study also asked about age at smoking initi-
ation. In the other surveys, age at smoking initiation was
calculated both for current (age at enrollment minus
duration of smoking in years) and former (age at enroll-
ment minus years since quitting and duration of smok-
ing in years) smokers. Current smokers were defined asthose who were daily smokers, and former smokers
were classified according to years since quitting smok-
ing, or if they answered that they had smoked previ-
ously but were not smokers at the time of enrollment.
We then combined the categories of current and
former smokers into a single category of ever smokers.
Ever smokers were further categorized according to the
following factors at enrollment: age at smoking initi-
ation in years (≤19, 20–24, ≥25), number of cigarettes
smoked per day (1–9, 10–19, ≥20), smoking duration in
years (1–19, 20–29, ≥30), and number of pack-years
smoked (i.e., number of cigarettes smoked per day, di-
vided by 20, multiplied by the duration of smoking in
years; 0–9, 10–19, ≥20). Participants who were neither
current nor former smokers were classified as never
smokers and constituted the reference group through-
out the present paper.
Body mass index (BMI) was calculated as weight in
kilograms divided by the square of height in meters.
The participants were categorized into three different
groups based on the level of physical activity reported
in the baseline questionnaires: sedentary (reading, watch-
ing television, and sedentary activity); moderate (walking,
bicycling, or similar activities ≥4 hours a week) and heavy
(heavy exercise and daily competitive sports and light
sports or heavy gardening ≥4 hours). The most recent in-
formation regarding duration of education was obtained
from Statistics Norway and participants were divided into
three categories by duration of education in years (<10,
10–12, and ≥ 13).
Follow-up and endpoints
We followed the participants who completed the base-
line questionnaire in one of the four health surveys from
1972 until 2003 through linkage to the Cancer Registry
of Norway and the Central Population Register, utilizing
the unique 11-digit personal identification number to
identify all cancer cases, emigrations and deaths, respect-
ively. These national registries are both accurate and virtu-
ally complete [15,16]. The start of follow-up was set as
1 January of the year after completing the baseline
questionnaire. Person-years were calculated from the
start of follow-up to the date of rectal cancer diagnosis,
the date of any incident cancer diagnosis (except skin
basal cell carcinoma), emigration, death, or the end of
follow-up, i.e., 31 December 2007, whichever occurred
first. Rectal cancer was classified according to the code
specified in the Seventh Revision of the International Stat-
istical Classification of Diseases (i.e., ICD-7 code 154).
We excluded 11,476 participants who were diagnosed
with any invasive cancer prior to the start of the study,
and 1,009 participants who had emigrated or died before
the start of follow-up. We further excluded 6,299 partici-
pants with insufficient information on smoking history.
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tion on BMI (n = 5,107), physical activity (n = 8,210) and
education (n = 18,449), leaving 602,242 (49% men) in the
analytical cohort.
Statistical analysis
We used the t-test and the χ2 test to investigate dif-
ferences in the distribution of selected characteristics
between men and women with and without rectal
cancer and between ever and never smokers. The Cox
proportional hazards model was used with age as the
underlying time scale to estimate multivariate-adjusted
hazard ratios (HRs) with 95% confidence intervals (CIs)
for the associations between different measures of smok-
ing exposure [age at smoking initiation in years (≤19,
20–24, ≥25), number of cigarettes smoked per day (1–9,
10–19, ≥20), smoking duration in years (1–19, 20–29, ≥30)
and number of pack-years smoked (0–9, 10–19, ≥20)]
and rectal cancer with never smokers as the reference
group. All analyses were done by gender. Entry time was
defined as age at enrollment and exit time was age at
diagnosis of rectal cancer, the date of any incident can-
cer diagnosis (except basal cell carcinoma), emigration,
death, or the end of follow-up (31 December, 2007),
whichever occurred first. The possible confounders
included in the final models, selected a priori, were
age at enrollment(continuous), level of physical activity
(sedentary, moderate and heavy), BMI(continuous), all
at enrollment, and duration of education in years
(<10, 10–12, ≥13). Tests for linear trends were obtained
by creating an ordinal exposure (including never smokers)
variable with equally spaced scores and including it in
the models.
We excluded 8,151 (99% men) participants who re-
ported smoking only cigar or pipe and did a sensitivity
analyses in this sub cohort. We had information on alco-
hol consumption for 37% (n = 221,748) of the total ana-
lytical cohort and did sensitivity analyses for the risk of
rectal cancer by gender for this subcohort (49% men)
with and without adjustment for alcohol consumption.
Heterogeneity by gender in the effect of smoking and risk
of rectal cancer was tested with the Wald χ2 test. Two-
sided p -values of <0.05 were considered statistically
significant. All analyses were conducted using STATA
version 12.0 (Stata Corp., College Station, TX, USA).
Results
During a mean follow up period of 14 years and 8.6 mil-
lion person-years of observation, 2,176 (61% men) histo-
logically confirmed invasive rectal cancer cases were
ascertained. Mean age at rectal cancer diagnosis for men
varied from 57 years in the 40 years cohort to 66 years
in the CONOR and the Oslo study I and for women, it
varied from 55 years in the 40 years cohort to 66 yearsin the CONOR study. At enrollment, 67% of men and
59% of women were ever smokers (Table 1). Compared
with never smokers, both men and women ever smokers
had less education, were less physically active and were
leaner (all p -values <0.0001) (data not shown).
Table 2 shows that the multivariate adjusted HR esti-
mate for rectal cancer was similar for current and
former smokers of both genders. Ever smokers had a
significantly increased risk of rectal cancer of more than
25% for both men (HR = 1.27, 95% CI = 1.11-1.45) and
women (HR = 1.28, 95% CI = 1.11-1.48) compared with
gender-specific never smokers. Men smoking ≥20 pack-
years had a significantly increased risk of rectal cancer
of 35% (HR = 1.35, 95% CI = 1.14-1.58), whereas for
women it was 47% (HR = 1.47, 95% CI = 1.13-1.91) com-
pared with gender-specific never smokers. For both
men and women, we observed significant dose–re-
sponse associations (including the reference category)
between the four variables [age at smoking initiation in
years (both ptrend <0.05), number of cigarettes smoked
per day (both ptrend <0.0001), smoking duration in years
(ptrend <0.05, <0.0001) and number of pack-years smoked
(both ptrend <0.0001)] and rectal cancer (Table 2). The test
for heterogeneity by gender was not significant between
smoking status and the risk of rectal cancer (Wald χ2,
p value; current smokers = 0.85; former smokers = 0.87;
ever smokers = 1.00). These estimates did not differ ma-
terially when we excluded participants who smoked
only cigars or pipes (data not shown).
In the sensitivity analyses for men with information on
alcohol consumption most of whom were enrolled after
1995, the risk estimate of rectal cancer incidence was 13%
(HR = 1.13, 95% CI = 0.83-1.55) with adjustment for alco-
hol consumption and 12% (HR = 1.12, 95% CI = 0.82-1.54)
without adjustment for alcohol consumption among ever
compared with never smokers. The same analyses among
women rendered a risk estimate of 37% (HR = 1.37, 95%
CI = 0.99-1.92) with adjustment for alcohol consumption
and 39% (HR = 1.39, 95% CI = 1.00-1.94) without adjust-
ment for alcohol consumption.
Table 3 shows that among men, ever smokers had a
significantly increased risk of rectal cancer compared
with gender-specific never smokers for all three levels of
BMI (<25, 25–29, ≥ 30), duration of education in years
(<10, 10–12, ≥13) and level of physical activity (seden-
tary, moderate and heavy). For women, the correspond-
ing figure was significantly increased for eight of the
nine displayed categories (Table 3).
Discussion
Our study shows that ever smokers had a significantly
increased risk of rectal cancer, and that this risk is simi-
lar for men and women. A possible causal interpretation
of our results is supported by the presence of a
Table 1 Selected characteristics of the study population at enrollment, stratified by cohort, among 602,242 Norwegian men and women (1972–2003)
Characteristics Oslo study Ia
(1972–1973)
Norwegian counties study
(1974–1987)
40 years cohort (1985–1999) CONOR (Cohort of Norway)
(1994–2003)
All (1974–2003)
Men Men Women Men Women Men Women Men Women
Subjects 16,946 41,913 41,573 185,037 199,730 55,480 61,563 299,376 302,866
Person- years of follow-up 476,518 1, 058, 699 1,079, 213 2,424,435 2,595, 800 462,398 516,186 4,422, 049 4,191,200
Age at enrollment, mean, SD 45 ± 6 40 ± 7 40 ± 7 43 ± 5 43 ± 5 48 ± 14 48 ± 15 44 ± 8 44 ± 8
Age at rectal cancer
diagnosis, mean, SD
66 ± 8 62 ± 8 63 ± 8 57 ± 10 55 ± 9 66 ± 11 66 ± 14 62 ± 10 59 ± 11
Year of birth, median, (Range) 1929(1925–1931) 1938(1932–1944) 1939(1932–1944) 1951(1948–1954) 1951(1948–1954) 1954(1940–1960) 1955(1941–1960) 1950(1944–1954) 1951(1946–1955)
Number of cases 286 366 281 504 426 180 133 1,336 840
Follow-up years,
median, (Range)
32(24–33) 28(20–30) 30(20–31) 13(10–16) 13(10–16) 9(6–10) 9(6–10) 13(10–18) 12(9–17)
≥13 years of educationb, (%) 24 14 12 26 22 21 21 23 20
Body mass index (BMI),
mean, (kg/m2)
25 25 24 26 24 26 25 26 25
Level of physical activity,
heavyc (%)
20 31 11 35 21 38 28 34 21
Ever smokers (%) 79 74 54 66 61 62 56 67 59
Current smokers (%) 55 51 40 40 40 31 32 41 38
Former smokers (%) 24 23 14 26 21 31 24 26 21
SD standard deviation, Range interquartile range. aIncluded only men. bNot at enrollment. cHeavy physical activity: Light sports or heavy gardening ≥ 4 hours per week, heavy exercise or daily competitive sports.
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Table 2 Multivariatea adjusted hazard ratio (HR) estimates for rectal cancer with 95% confidence intervals (CI) among
women (n = 302,866) and men (n = 299,376) according to various measures of smoking exposure at enrollment,
compared with never smokers
Men Women
Cases n = 1,336 Person-years HR 95% CI Cases n = 840 Person-years HR 95% CI
Smoking status
Never 298/98,388 1,369,691 1.00 Ref. 350/123,503 1,744,944 1.00 Ref.
Former 433/78,662 1,138,881 1.28 1.11-1.50 169/64,021 824,913 1.26 1.05-1.52
Current 605/122,326 1,913,477 1.26 1.09-1.45 321/115,342 1,621,343 1.29 1.10-1.51
Ptrendb <0.05 <0.05
Ever 1,038/200,988 3,052,358 1.27 1.11-1.45 490/179,363 2,446,256 1.28 1.11-1.48
Ever smokersc
Age at smoking initiation in years
≥25 116/16,415 268,600 1.23 0.99-1.52 99/23,150 357,101 1.19 0.95-1.49
20-24 211/38,540 592,480 1.35 1.13-1.61 136/40,824 588,736 1.45 1.18-1.78
≤19 362/96,856 1,294,339 1.28 1.08 − 1.50 142/80,620 928,955 1.35 1.10-1.67
Ptrendb <0.05 <0.05
Number of cigarettes smoked per day
1-9 207/39,218 604,421 1.07 0.90-1.29 169/59,570 824,198 1.15 0.96-1.39
10-19 524/99,761 1,526,804 1.35 1.17-1.56 255/93,002 1,268,980 1.37 1.16-1.62
≥20 259/56,319 832,845 1.31 1.11-1.55 64/25,270 337,874 1.38 1.05-1.81
Ptrendb <0.0001 <0.0001
Smoking duration in years
1-19 326/80,190 1,250,222 1.21 1.03-1.42 220/87,999 1,263,528 1.17 0.99 − 1.40
20-29 457/97,685 1,471,526 1.29 1.11-1.50 222/81,713 1,089,772 1.37 1.15-1.64
≥30 232/21,144 299,518 1.31 1.09-1.59 48/7,918 76,398 1.54 1.11-2.12
Ptrendb <0.05 <0.0001
Number of pack-years smokedd
0-9 298/68,003 943,796 1.17 0.99-1.37 241/88,884 1,270,193 1.21 1.02-1.42
10-19 385/74,235 1,014,305 1.33 1.14-1.54 178/64,544 862,029 1.38 1.14-1.66
≥20 302/52,392 647,100 1.35 1.14-1.58 69/23,263 288,147 1.47 1.13-1.91
Ptrendb <0.0001 <0.0001
aAdjusted for age, body mass index, level of physical activity all at enrollment and duration of education. bNever smokers included in the model. cTotal numbers
of ever smokers do not equal the total in different smoking exposures due to missing values in different smoking exposures groups. dPack-years were calculated
as numbers of cigarettes smoked per day, divided by 20 and multiplied by the number of years smoked.
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ous measures of smoking exposure (i.e., age at smoking
initiation in years, number of cigarettes smoked per day,
smoking duration in years and number of pack-years
smoked) and the risk of rectal cancer for both genders.
Men and women ever smokers also had an increased
risk of rectal cancer within the different categories of
possible confounding variables, such as BMI, duration of
education and level of physical activity.
To our knowledge, this prospective analysis of smok-
ing and the risk of rectal cancer includes the largest
number of rectal cancer cases investigated to date. It is
also the first to compare this association in detail by
gender. In the present report, the association betweencigarette smoking and rectal cancer was similar for men
and women. Previously, we reported from the same co-
hort that smoking increased the risk of colon cancer to a
greater extent for women than men [2]. Our present
findings of no difference between the gender in the
smoking related increased risk of rectal cancer are in ac-
cordance with three [17-19] smaller Japanese cohort
studies including 200 cases of rectal cancer [19] or less
[17,18]. The European Prospective Investigation into
Cancer and Nutrition (EPIC) cohort with 950 incident
rectal cases among almost half a million men and
women from ten European countries [20], and the
Singapore Chinese Health Study with 329 rectal cancer
cases are the largest cohort studies including both
Table 3 Age and multivariatea adjusted HR estimates for rectal cancer with 95% CI among 602,242 Norwegian men
and women ever smokers according to selected covariates and never smokers as reference group
Men Women
Ever smokers Cases n = 1038 Multivariate adjusteda HR (95% CI) Cases n = 490 Multivariate adjusteda HR (95% CI)
Body mass index (kg/m2)
<25 484 1.17(1.01-1.36) 296 1.18(1.01-1.39)
25-29 466 1.33(1.15-1.54) 145 1.39(1.15-1.70)
≥30 88 1.53(1.20-1.95) 49 1.39(1-15-1.70)
Duration of education (years)b
<10 356 1.20(1.02-1.40) 185 1.22(1.02-1.47)
10-12 497 1.26(1.09-1.45) 248 1.31(1.11-1.55)
≥13 185 1.41(1.17-1.70) 57 1.28(0.96-1.70)
Level of physical activityc
Sedentary 241 1.36(1.15-1.62) 125 1.30(1.06-1.60)
Moderate 550 1.27(1.10-1.46) 292 1.24(1.05-1.46)
Heavy 247 1.22(1.03-1.45) 73 1.39(1.07-1.79)
aAdjusted for age, body mass index, physical activity all at enrollment and duration of education. bNot at enrollment. cLevel of physical activity; sedentary
(reading, watching television, and sedentary activity), moderate (walking, bicycling, or similar activities ≥4 hours per week), and heavy (light sports or heavy
gardening ≥4 hours per week, heavy exercise or daily competitive sports).
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smoking and the risk of rectal cancer [21]. The former
study found a non-significant increase in rectal cancer
among ever smokers [20] whereas the latter study found
a significantly increased risk [21]. Neither of these two
studies reported on the smoking-related risk of rectal
cancer by gender. Four other cohort studies included ei-
ther only women [22-24], or only men [25]. The studies,
from Canada [24] and the United States [23] showed
slightly higher risk estimates than ours, whereas the
studies from Norway [22], and Korea [25], had lower risk
estimates. The association between smoking and rectal
cancer achieved statistical significance only among current
smokers in the United States [23] and among former
smokers in the Canadian study [24]. In our study, for both
genders, former, current and ever smokers all had a sig-
nificantly increased risk of rectal cancer.
Two meta-analyses, one including 36 prospective co-
hort studies reported a non-significant almost 20% in-
creased risk of rectal cancer for both former and current
smokers [26] while the other comprised 106 observa-
tional studies and reported a significantly increased risk
of rectal cancer of 25% among ever smokers [27]. Nei-
ther of these meta-analyses reported gender-specific risk
estimates.
In studies reporting risk estimates by cancer site, the
association between smoking and rectal cancer has gen-
erally been stronger than that with colon cancer among
both men and women. Similarly, stronger relative risk
among ever smokers for proximal compared to distal
colon cancer has been documented [1]. In our previous
study [2], we found that the smoking-related risk ofcolon cancer was more pronounced in the proximal part
of colon for women, but not for men. For the distal part
of colon, we could not demonstrate a difference by gen-
der. These results, as well as those reported in the IARC
monograph, are in accordance with the findings of the
present study.
Colorectal cancer is considered a complex collection
of diseases with different etiologies [28]. Smoking causes
irreversible genetic damage in the colorectal mucosa due
to its carcinogenic effects, which lead to cancerous
changes. In 1996 Giovannucci et al. [29] hypothesized
that smoking is an initiator of colorectal carcinogenesis,
but that the increased risk only emerges 30 to 40 years
after smoking initiation. In an updated review study
from 2001, Giovannucci [30] reiterated his stand on this
issue, stating that the induction period could be from 35
to 40 years. The notion that cigarette smoking is consid-
ered an initiator rather than a promoter of rectal cancer
was also supported in the study by Terry et al. [24]. Our
results showed a significantly increased risk of rectal
cancer for smokers who had smoked for <20 years at en-
rollment for men and <30 years for women. When we
add the median follow-up time of 13 years for men and
12 years for women, our results showed an induction
period that is in accordance with the above suggestions.
Our study has several major strengths. It is based on a
large prospective cohort population from Norway com-
prising both men and women, with a long and virtually
complete follow-up. The long follow-up period resulted
in a large number of cases, and gave us more stable risk
estimates and results that are less prone to chance. We
were able to stratify all the analyses according to
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to conduct all analyses separately by gender. Also, smok-
ing histories were obtained at enrollment and, therefore,
are not subject to recall bias. We have a high proportion
of men and women ever smokers. In addition, we fo-
cused our analyses on the comparison between ever ver-
sus never smokers. Thus, it is only never smokers that
could have possibly changed their smoking status during
follow-up. As very few Norwegians start to smoke after
the age of 30 and the mean age at enrollment for our
study is more than 40 years, we are confident that pos-
sible changes in smoking status among never smokers
during follow-up did not influence our risk estimates.
We had information on, and were able to control for,
established risk factors for rectal cancer, many of which
varied according to smoking status. Rectal cancer screen-
ing was not in place in Norway during our study period,
thus reducing detection bias. Also, two previous reports
confirmed the internal validity of the association between
smoking exposure and the risk of breast [14] and colon
cancer [2].
Our study has also several limitations. We lacked in-
formation on family history of rectal cancer and on diet-
ary factors, such as alcohol and red meat consumption,
which are established risk factors for rectal cancer. In-
creased consumption of alcohol and red meat are factors
that may partly explain the steep increase in rectal can-
cer incidence for both genders. Alcohol consumption is
higher among men than women in Norway [31]. Thus,
the lack of adjustment for alcohol consumption in our
main analyses is likely to have inflated the estimates
among men more than women, thereby, biasing a poten-
tial gender difference. However, in the subcohort ana-
lyses, the risk estimates were similar for men ever
smokers with and without adjustment for alcohol con-
sumption. This was also the case for women. This indi-
cates that our results may be noteworthy in spite of the
lack of data on alcohol consumption for the majority of
the subjects in the main analyses. Rectal cancer has a
long induction period [30] and the interpretation of our
sensitivity analyses should be done with caution, as they
included fewer cases and younger participants with
less follow-up time compared to the main cohort. If
Norwegian men consumed more red meat than women,
this would bias a potential gender difference in the same
direction as alcohol consumption. However, we cannot
rule out that alcohol and red meat consumption may have
stronger effects in women than men.
Similarly, information on the use of COX inhibitors,
such as aspirin, which has preventive effects on rectal
cancer development [32] was not available. The lack of
molecular data is another limitation. We also lacked de-
tailed information on occasional and passive smoking.
From 1976 to 2006, which is during our follow-upperiod, around 10% of the Norwegian population re-
ported smoking occasionally [33]. We believe that some
occasional smokers may have been excluded due to in-
sufficient smoking information, whereas others may have
been included in the reference group, together with
women exposed to passive smoking, which would have
attenuated the associations between smoking and rectal
cancer. As current smokers have an increased risk of
dying from any major cause during follow-up and rectal
cancer is assumed to take many years, competing causes
of death may decrease the impact of smoking more
among current than former smokers, and make the asso-
ciation with rectal cancer more similar for current and
former smokers. There may be some residual confound-
ing due to these and other unknown risk factors. Never-
theless, the dose–response association we observed is
suggestive of a causal association between smoking and
rectal cancer for both men and women.
Conclusions
Smoking increases the risk of rectal cancer to the same
extent in women as in men.
Abbreviations
BMI: Body mass index; CI: Confidence interval; CONOR: Cohort of Norway;
EPIC: European Prospective Investigation into Cancer and Nutrition;
IARC: International Agency for Research on Cancer; ICD: International
classification of diseases; HR: Hazard ratio; SD: Standard deviation.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
RP carried out the statistical analysis and drafted the manuscript. ITG, EW
and EB contributed to the planning of the manuscript, statistical analysis,
interpretation of the data and critical revision of the manuscript. AT
contributed with statistical analysis interpretation of data and critical
revision of the manuscript. LM contributed with interpretation of the data
and critical revision of the manuscript. All authors read and approved the
final version of the manuscript.
Acknowledgements
The research project was supported by the Norwegian Cancer Society as a
PhD project for the main author Dr. Ranjan Parajuli (grant numbers: PK
2009–0430 and PK01-2009-0341). This work was mainly carried out at UiT,
the Artic University of Norway and while Professor Inger T. Gram was a Visiting
Scholar at the Cancer Research Centre of Hawaii, University of Hawaii. The
authors wish to acknowledge the services of the CONOR, the contributing
research centers delivering data to CONOR and all the study participants.
This paper was approved by the CONOR steering committee. The authors
also thank Professor Anders Engeland, Senior researcher Randi Selmer, Data
manager Knut Hansen and Data analyst Ilene Brill for helping us to merge
the different surveys and to prepare the master data file and associate
Professor Tonje Braaten for her assistance in statistical analysis.
Author details
1Department of Community Medicine, Faculty of Health Sciences, UiT, The
Arctic University of Tromsø, Tromsø, Norway. 2Division of Epidemiology,
Department of Pharmacoepidemiology, Norwegian Institute of Public Health,
P.O. Box 4404, Nydalen, 0403 Oslo, Norway. 3Epidemiology Program,
University of Hawaii Cancer Center, Honolulu, HI, USA. 4Department of
Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm,
Sweden. 5Department of Genetic Epidemiology, Samfundet Folkhälsan,
Helsinki, Finland. 6Department of Research, Cancer Registry of Norway, Oslo,
Parajuli et al. BMC Cancer 2014, 14:321 Page 8 of 8
http://www.biomedcentral.com/1471-2407/14/321Norway. 7Norwegian Centre for Integrated Care and Telemedicine, University
Hospital of North Norway, Tromsø, Norway.
Received: 8 November 2013 Accepted: 1 May 2014
Published: 6 May 2014References
1. IARC: Monographs on the Evaluation of Carcinogenic Risks to Humans.
Personal Habits and Indoor Combustions. A Review of Human Carcinogens.
Lyon, France: IARC Press; 2012:vol 100E.
2. Parajuli R, Bjerkaas E, Tverdal A, Selmer R, Le Marchand L, Weiderpass E,
Gram IT: The increased risk of colon cancer due to cigarette smoking
may be greater in women than men. Cancer Epidemiol Biomarkers Prev
2013, 22:862–871.
3. Lopez AD, Collishaw NE, Piha T: A descriptive model of the cigarette
epidemic in developed countries. Tob Control 1994, 3:242–247.
4. Thun M, Peto R, Boreham J, Lopez AD: Stages of the cigarette epidemic
on entering its second century. Tob Control 2012, 21:96–101.
5. Helleve A, Weisæth A, Lindbak R: Tall om tabakk 1973-2009(Figures about
tobacco 1973–2009). Oslo, Norway: Norwegian directorate of Health; 2010.
6. Norges offentlige utredninger: Tobakksindustriens erstatningsansvar[Tobacco
industryliability]. Norway’s public reports, Volume 16. Oslo, Norway: Statens
forvaltningstjeneste, Informasjonsforvaltning.NOU; 2000:1–661.
7. Cancer Registry of Norway: Cancer in Norway 2011 - Cancer Incidence,
Mortality, Survival and Prevalence in Norway. Oslo: Cancer Registry of
Norway; 2013.
8. Bjartveit K, Foss OP, Gjervig T, Lund-Larsen PG: The cardiovascular disease
study in Norwegian counties. Background and organization. Acta Med
Scand Suppl 1979, 634:1–70.
9. Bjartveit K, Stensvold I, Lund-Larsen PG, Gjervig T, Kruger O, Urdal P:
Cardiovascular screenings in Norwegian counties. Background and
implementation. Status of risk pattern during the period 1986–90
among persons aged 40–42 years in 14 counties. Tidsskr Nor Laegeforen
1991, 111:2063–2072.
10. Leren P, Askevold EM, Foss OP, Froili A, Grymyr D, Helgeland A, Hjermann I,
Holme I, Lund-Larsen PG, Norum KR: The Oslo study. Cardiovascular
disease in middle-aged and young Oslo men. Acta Med Scand Suppl 1975,
588:1–38.
11. Naess O, Sogaard AJ, Arnesen E, Beckstrom AC, Bjertness E, Engeland A,
Hjort PF, Holmen J, Magnus P, Njolstad I, Tell GS, Vatten L, Vollset SE,
Aamodt G: Cohort profile: cohort of Norway (CONOR). Int J Epidemiol
2008, 37:481–485.
12. Solberg LA, Strong JP, Holme I, Helgeland A, Hjermann I, Leren P,
Mogensen SB: Stenoses in the coronary arteries. Relation to
atherosclerotic lesions, coronary heart disease, and risk factors. The Oslo
Study. Lab Invest 1985, 53:648–655.
13. Stocks T, Borena W, Strohmaier S, Bjorge T, Manjer J, Engeland A, Johansen
D, Selmer R, Hallmans G, Rapp K, Concin H, Jonsson H, Ulmer H, Stattin P:
Cohort Profile: the Metabolic syndrome and Cancer project (Me-Can).
Int J Epidemiol 2010, 39:660–667.
14. Bjerkaas E, Parajuli R, Weiderpass E, Engeland A, Maskarinec G, Selmer R,
Gram IT: Smoking duration before first childbirth: an emerging risk factor
for breast cancer? Results from 302,865 Norwegian women. Cancer
Causes Control 2013, 24:1347–1356.
15. Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F,
Moller B: Data quality at the Cancer Registry of Norway: an overview of
comparability, completeness, validity and timeliness. Eur J Cancer 2009,
45:1218–1231.
16. Svensson E, Grotmol T, Hoff G, Langmark F, Norstein J, Tretli S: Trends in
colorectal cancer incidence in Norway by gender and anatomic site: an
age-period-cohort analysis. Eur J Cancer Prev 2002, 11:489–495.
17. Otani T, Iwasaki M, Yamamoto S, Sobue T, Hanaoka T, Inoue M, Tsugane S:
Alcohol consumption, smoking, and subsequent risk of colorectal cancer
in middle-aged and elderly Japanese men and women: Japan Public
Health Center-based prospective study. Cancer Epidemiol Biomarkers Prev
2003, 12:1492–1500.
18. Shimizu N, Nagata C, Shimizu H, Kametani M, Takeyama N, Ohnuma T,
Matsushita S: Height, weight, and alcohol consumption in relation to the
risk of colorectal cancer in Japan: a prospective study. Br J Cancer 2003,
88:1038–1043.19. Wakai K, Hayakawa N, Kojima M, Tamakoshi K, Watanabe Y, Suzuki K,
Hashimoto S, Tokudome S, Toyoshima H, Ito Y, Tamakoshi A: Smoking and
colorectal cancer in a non-Western population: a prospective cohort
study in Japan. J Epidemiol 2003, 13:323–332.
20. Leufkens AM, Van Duijnhoven FJ, Siersema PD, Boshuizen HC, Vrieling A,
Agudo A, Gram IT, Weiderpass E, Dahm C, Overvad K, Tjonneland A, Olsen A,
Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Palli D, Grioni S, Tumino R,
Sacerdote C, Mattiello A, Herman S, Kaaks R, Steffen A, Boeing H, Trichopoulou
A, Lagiou P, Trichopoulos D, Peeters PH, van Gils CH, van Kranen H, et al:
Cigarette smoking and colorectal cancer risk in the European Prospective
Investigation into Cancer and Nutrition study. Clin Gastroenterol Hepatol
2011, 9:137–144.
21. Tsong WH, Koh WP, Yuan JM, Wang R, Sun CL, Yu MC: Cigarettes and
alcohol in relation to colorectal cancer: the Singapore Chinese Health
Study. Br J Cancer 2007, 96:821–827.
22. Gram IT, Braaten T, Lund E, Le Marchand L, Weiderpass E: Cigarette
smoking and risk of colorectal cancer among Norwegian women. Cancer
Causes Control 2009, 20:895–903.
23. Paskett ED, Reeves KW, Rohan TE, Allison MA, Williams CD, Messina CR,
Whitlock E, Sato A, Hunt JR: Association between cigarette smoking and
colorectal cancer in the Women’s Health Initiative. J Natl Cancer Inst 2007,
99:1729–1735.
24. Terry PD, Miller AB, Rohan TE: Prospective cohort study of cigarette
smoking and colorectal cancer risk in women. Int J Cancer 2002,
99:480–483.
25. Yun YH, Jung KW, Bae JM, Lee JS, Shin SA, Min PS, Yoo T, Yul HB: Cigarette
smoking and cancer incidence risk in adult men: National Health
Insurance Corporation Study. Cancer Detect Prev 2005, 29:15–24.
26. Liang PS, Chen TY, Giovannucci E: Cigarette smoking and colorectal
cancer incidence and mortality: systematic review and meta-analysis.
Int J Cancer 2009, 124:2406–2415.
27. Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P:
Smoking and colorectal cancer: a meta-analysis. JAMA 2008,
300:2765–2778.
28. Boland CR, Goel A: Clearing the air on smoking and colorectal cancer.
J Natl Cancer Inst 2010, 102:996–997.
29. Giovannucci E, Martinez ME: Tobacco, colorectal cancer, and adenomas: a
review of the evidence. J Natl Cancer Inst 1996, 88:1717–1730.
30. Giovannucci E: An updated review of the epidemiological evidence that
cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol
Biomarkers Prev 2001, 10:725–731.
31. Strand BH, Steiro A: [Alcohol consumption, income and education in
Norway, 1993–2000]. Tidsskr Nor Laegeforen 2003, 123:2849–2853.
32. Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, Meade
TW: Long-term effect of aspirin on colorectal cancer incidence and
mortality: 20-year follow-up of five randomised trials. Lancet 2010,
376:1741–1750.
33. Lund M, Lindback R: Norwegian Tobacco Statistics 1973–2006. SIRUS- Writings
3/2007. 2007.
doi:10.1186/1471-2407-14-321
Cite this article as: Parajuli et al.: Smoking increases rectal cancer risk to
the same extent in women as in men: results from a Norwegian cohort
study. BMC Cancer 2014 14:321.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
